After stock slides, Amgen addresses bone density talk on obesity drug

A lot of Amgen’s future rides on its experimental obesity medicine MariTide. At least in the minds of investors.

Ahead of the biopharma’s most critical …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Police arrest person of interest in connection with killing of UnitedHealthcare CEO

Authorities have arrested a person of interest in connection with the fatal shooting of UnitedHealthcare CEO Brian Thompson. The arrest came after a days-long manhunt

December 10, 2024

Overcoming the first hurdles: Navigating early phase challenges for biotechs – Pharmaceutical Technology

The clinical trial landscape is changing. What do organisers need to know to navigate potential disruption? Source: Shutterstock. As smaller, leaner organisations that must utilise

December 11, 2024

Risk Adjusted Net Present Value: What is the current valuation of HilleVax’s HIL-214

The revenue for HIL-214 is expected to reach an annual total of $24 mn by 2039 in the US based off GlobalDatas Expiry Model. The

September 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.